These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1835446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of cytochrome P-450 mRNAs in steroidogenesis of adrenocortical adenomas from patients with primary aldosteronism.
    Ogo A, Haji M, Ohashi M, Nawata H.
    Mol Cell Endocrinol; 1991 Apr; 76(1-3):7-12. PubMed ID: 1820978
    [Abstract] [Full Text] [Related]

  • 3. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
    Enberg U, Farnebo LO, Wedell A, Gröndal S, Thorén M, Grimelius L, Kjellman M, Bäckdahl M, Hamberger B.
    World J Surg; 2001 Jul; 25(7):957-66. PubMed ID: 11572038
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Disordered expression of adrenal steroidogenic P450 mRNAs in incidentally discovered nonfunctioning adrenal adenoma.
    Ogo A, Haji M, Ohashi M, Takayanagi R, Yanase T, Nawata H.
    Endocrinol Jpn; 1992 Feb; 39(1):73-80. PubMed ID: 1535042
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Editorial comment from Dr Fang to increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas.
    Fang Y.
    Int J Urol; 2011 Oct; 18(10):697-9. PubMed ID: 21883494
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Steroid 21-hydroxylase and 17 alpha-hydroxylase in microsomal fraction of functioning adrenocortical tumors.
    Naganuma H, Sasano N.
    Tohoku J Exp Med; 1989 Jul; 158(3):253-62. PubMed ID: 2799809
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
    Nawata H, Higuchi K, Yanase T, Takayanagi R, Kato K, Ibayashi H.
    Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
    [Abstract] [Full Text] [Related]

  • 15. Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes.
    Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T, Sasano H.
    Endocr J; 2001 Apr; 48(2):167-74. PubMed ID: 11456263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas.
    Sakai Y, Yanase T, Hara T, Takayanagi R, Haji M, Nawata H.
    J Clin Endocrinol Metab; 1994 Jan; 78(1):36-40. PubMed ID: 8288710
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G, Camanni F, Messina M.
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.